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1078–5Background and purpose. Echolucent carotid plaques, as well as downstream micro-embolisation, may be associated with
an increased risk of stroke. However, the relationship between carotid plaque ultrasound characteristics and micro-embolic
signals (MES) detected in the middle cerebral artery (MCA) is still controversial. The purpose of this study was to inves-
tigate the prevalence of MES in patients with symptomatic high-grade internal carotid artery (ICA) stenosis and to identify
predisposing factors, such as plaque echogenicity and intra stenotic blood flow velocity pattern.
Methods. 197 patients (mean age 69.5 8.6, 161 males) with confirmed symptomatic high-grade ICA stenosis and anti-
platelet treatment underwent bilateral MES monitoring for 30 minutes within the anterior circulation, using Power
M-mode transcranial Doppler techniques (TCD). Carotid artery plaques were characterized by Gray-Weale scaling.
Results. In 32.0% of the patients, we detected MES by TCD within the MCA on the symptomatic side, but the same find-
ing was made in only 4.5% on the corresponding asymptomatic site (p< 0.0001). The presence or absence of MES was
associated with neither ultrasonic plaque characteristics nor the intrastenotic blood flow velocities at peak systole and end
diastole. The median time since the last ischemic event symptoms was shorter in the patient group with MES [þ] than in
MES [] (p¼ 0.013).
Conclusions. Despite optimum standard anti-platelet therapy, cerebral micro-embolisation occurs in 30% of patients with
symptomatic carotid artery disease, which might therefore be a possible risk factor for recurrent neurological symptoms.
However, the presence of MES is independent of intrastenotic blood flow disturbances and grey scale ultrasound plaque
characteristics. The presence of MES as an indicator of unstable plaque and thereby a possible risk factor for stroke should
be evaluated prospectively using various algorithms for plaque classifications.
 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Doppler.Introduction
Stroke is the third leading cause of death in the devel-
oped countries after heart diseases and cancer. A sig-
nificant percentage of strokes are caused by emboli
arising from atherothrombotic carotid artery stenosis,
which therefore is a risk factor for ischemic stroke.1,2
Carotid endarterectomy (CEA) significantly reduces
the incidence of stroke in patients with symptomatic
extracranial carotid artery stenosis of 70e99%.3,4
However, CEA is not free from risk and not all pa-
tients with a transient ischemic attack (TIA) or strokesponding author. R. Volkmann, Department of Molecular and
l Medicine, Clinical Physiology, SE 41345 Go¨teborg, Sweden.
address: volk@medfak.gu.se
884/000534+ 07 $34.00/0  2008 European Society for Vasculacaused by ipsilateral carotid stenosis will suffer of
recurrent stroke on medical treatment alone. In addi-
tion, the management of patients with either high-
grade asymptomatic internal carotid artery (ICA)
stenosis, or those with a mild to moderate symptom-
atic stenosis accompanied by heterogeneous irregular
(‘‘unstable’’) plaque, is still uncertain. In these cases,
the indications for CEA can still be discussed. Poten-
tially the selection of patients for CEA might be
improved if the evidence based data about the degree
of stenosis is complemented by plaque instability
markers such as cerebral micro-emboli.
Transcranial Doppler (TCD) detects spontaneous
micro-embolic signals (MES) within the relevant intra-
cranial arteries as a probable risk of future stroke.5e7
In 79% of patients with ulcerated carotid plaque, asr Surgery. Published by Elsevier Ltd. All rights reserved.
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cerebral artery (MCA).8 Hypo-echogenic carotid pla-
ques were also associated with a higher probability
of intracranial MES.9 Clinically silent micro-emboli
might indicate the presence of fragile macro-thrombi
which might cause major stroke.10 However, the
important question of whether the detection of MES
is an independent risk factor for the occurrence of
stroke still remains.
The purpose of this study was to investigate the
prevalence and frequency of micro-embolisation to
the relevant MCA/ACA in patients with symptomatic
severe carotid stenosis. We correlated the occurrence
of MES to the grey-scale ultrasound characteristics
of the carotid plaque, the intra stenotic blood flow
velocity, stroke risk factors and the time since the
last ischemic event.Patients and Methods
Between January 2004 and July 2005, 214 consecutive
patients (mean age 68.4 8.4 yrs) were prospectively
recruited at Sahlgrenska University Hospital (Go¨te-
borg, Sweden). All subjects had been referred for
preoperative TCD investigation due to a high-grade
ICA stenosis according to the ECST definitions11 and
a history of recent ischemic eventswithin the ipsilateral
carotid artery circulation. In 17 (7.9%) patients the
transtemporal TCD investigations were inconclusive
because of absent temporal windows. The remaining
197 patients (161 males and 36 females, mean age
69.5 8.6 yrs) with symptomatic ICA 70e99% stenoses
weremonitored by powerM-mode TCD. In 19 patients
the transtemporal TCD investigations on the asymp-
tomatic side were inconclusive because of absent
temporal windows. As a result, 178 asymptomatic
ICA vessels were successfully monitored for MES and
included for further analysis. A recent ischemic event
was considered if amaurosis fugax (AFX), TIA orminor
stroke occurredwithin a six-month period. All patients
were on anti-platelet therapy (aspirin and/ordipyrida-
mole and/or clopidogrel). Besides the common exclu-
sion criteria for CEA, patients with atrial fibrillation
or flutter; cardiac valve prosthesis; or evidence of other
sources of embolism (cardiogenic or paradoxical); were
excluded. Therefore, transesophageal echocardio-
graphy was not performed due to the lack of clinical
indications. The TCD investigations were part of the
local routines for pre-operative carotid evaluations
and approved by the local ethics committee.
The severity of the carotid stenosis was defined by
colour-coded ultrasound (CDI, Sequoia 512, Siemens
Acuson Corp.) using linear transducers (6e8 MHz)to measure the intra-stenotic peak systolic and end di-
astolic velocities.12e14 The local techniques of CDI had
been previously validated against selective carotid
angiography with outcomes comparable with other
Swedish materials.12,14 Patients were subdivided
with respect to the maximum systolic blood flow ve-
locities into groups with <70%, 70% diameter reduc-
tions or ICA occlusions and high-grade stenosis with
string flow pattern. Peak systolic velocities of >1.9 m/s
[Doppler beam angulations 40, calculated from,14
(Table 4)] or >2.5 m/s [Doppler angulations of 60, 14]
were the cut-off velocities for ICA stenosis of
70%. There are significant inter individual spreads
of the blood flow velocities in similar grades of ICA
stenosis disturbing attempts to array carotid artery
disease into 10% incremental steps.15e17 However, in
our hands, TCD gave additional hemodynamic in-
formation for more reliable carotid artery disease
gradations.
Plaque characteristics were assessed by Gray-Weale
scaling as modified by Geroulakos & Sabetai:18,19
Type 1: predominantly echolucent lesions with
a thin echogenic cap;
Type 2: intermediate echolucent lesions with small
areas of echogenicity;
Type 3: intermediate echogenic lesions with small
areas of echolucency (< 25%);
Type 4: uniformly echogenic lesions (equivalent to
homogeneous);
Type 5: plaque with acoustic shadowing artefact.
Independently of the TCD outcomes, this subjective
scaling has been performed by two trained investiga-
tors since its introduction in the department’s clinical
routines,20 but inter observer variations of the ultra-
sound plaque characterization was not evaluated in
this study.
MES detection was performed according to Moehr-
ing et al.,21 using the transcranial Power M-mode
(PMD) technique (PMD100, Spencer Technologies).
2 MHz ultrasound transducers were fixed over each
side’s temporal window to insonate the distal ICA
siphon, the MCA and the anterior cerebral artery
(ACA). MES were monitored within a multigated
PMD spectrum using 33 sample volumes arrayed
within a depth range of 28e82 mm from the temporal
bone (Fig. 1). An additional sample volume channel
presented the blood flow velocity spectrogram at
depths ranging between 50e60 mm (Fig. 1). The pa-
tients underwent continuous 30-minute monitoring
the days before CEA. MES were detected and counted
within the Doppler spectrum using basic identifica-
tion criteria of Doppler micro-embolic signals22 andEur J Vasc Endovasc Surg Vol 35, May 2008
Fig. 1. Detection of microembolic signals by transcranial
Power M-Mode (PMD) Doppler. Upper display shows
a red PMD-spectrum representing distal parts of the siphon
and proximal parts of the MCA. ACA flow spectrum not
visible. The line at 60 mm depth represents position of the
sample volume for spectral analysis of the Doppler flow
velocities. Note a MES in red colour moving from around
70 mm depth to M1, and another one in blue colour from
the same origin into the ACA region. The lower display
shows the velocity spectrum, which is disturbed only by
the MCA MES but not by the ACA MES. MCA e middle
cerebral artery; ACA e anterior cerebral artery; ‘A’ and
arrow indicates detected MES within the PMD and Doppler
spectrum.
536 T. Zuromskis et al.according to embolic signatures within the Power M-
Mode spectrum, which should be visible at least 3 dB
higher than the highest spontaneous PMD display of
background blood flow signal; and reflect motion in
one direction. MES within the MCA move towards
the probe with a positively sloping track. MES within
the ACA move away from the probe with a negatively
sloping track.23
In order to test the collateral compensation through
the circle of Willis and to verify the flow of MCA and
ACA, a manual compression of the proximal common
carotid artery (comp-CCA) was performed during
10 heartbeats.24Analysis and statistics
Statistical analysis was performed using SPSS v.11.0
data analysis package. Normally distributed variablesTable 1. Number of patients with and without spontaneous micro-em
the functional degree of ICA stenosis
Symptomatic side (N¼ 19
MES [þ] (N¼ 63) M
<70% e e
70% 61/191 (31.9%) 1
ICA stenosis with string flow pattern 2/6 (33.3%) 4
100% (occlusion) e e
MES [þ] e patients with micro-emboli during 30 minutes of TCD mo
MES [] e patients without micro-embolisations;
* in all cases, MES were collateral.
Eur J Vasc Endovasc Surg Vol 35, May 2008were reported as absolute values and percentages, or
mean values and standard deviations. Variables that
do not follow the normal distribution were expressed
as median and interquartile range (IQR). McNemar
test was applied evaluating the difference of microem-
bolic activity on symptomatic and asymptomatic
sides. Spearman’s rank correlation coefficient was
used to assess correlation between number of MES
and number of days since the last ischemic event. Stu-
dent’s unpaired two-tailed t test was used to compare
the means of normal distributed variables. Nonpara-
metric Kruskal-Wallis and Mann-Whitney U tests
were applied comparing variables that did not follow
normal distribution (non-normal). c2 test and Fisher’s
exact test were performed to test the null hypothesis
that the distribution of a discontinuous variable is
the same in two groups. A p-value< 0.05 was consid-
ered to prove statistically significant difference. For
statistical analysis all successfully monitored patients
were subdivided into two groups (MES [þ] and
MES [e]) according to the presence of detected MES.Results
The number of MES detected within 30 minute TCD
monitoring ranged from one to 24. Spontaneous
MES were registered in 63/197 (32.0%) cases on the
symptomatic side and in 8/178 (4.5%) cases on the
asymptomatic side. Registered MES have never been
accompanied by evolution of new neurological symp-
toms. Table 1 shows the occurrence of MES in asymp-
tomatic and symptomatic sides and patient subgroups
with different severities of the ICA stenosis. The inci-
dence of MES did not change in subgroups of blood
flow velocities above the cut-off value of 70% steno-
sis on the symptomatic side. Successful bilateral TCD
monitoring of 178 patients with unilateral symptoms
revealed MES within the symptomatic side in 33.7%
subjects while only in 4.5% within the asymptomatic
side (McNemar’s test, p< 0.0001). Furthermore, com-
paring the occurrence of MES in the presence of bilat-
eral 70% ICA stenosis, the symptomatic side wasbolisation on asymptomatic and symptomatic sides as related to
7) Asymptomatic side (N¼ 178)
ES [] (N¼ 134) MES [þ] (N¼ 8) MES [] (N¼ 170)
2/129 (1.6%) 127/129 (98.4%)
30/191 (68.1%) 2/38 (5.3%) 36/38 (94.7%)
/6 (66.7%) 1/4 (25.0%) 3/4 (75.0%)
3/7 (42.9%)* 4/7 (57.1%)
nitoring;
537Prevalence of Micro-Emboli in Symptomatic High Grade Carotid Artery Diseasefive times more embologenic (15/42, 35.7%) than the
asymptomatic one (3/42, 7.1%) (McNemar’s test,
p< 0.0001).
In two cases, MES (1 MES/30 min and 6 MES/
30 min respectively) were registered on the asymp-
tomatic side with ICA stenosis of <70% and with
signs of intracranial ICA siphon stenosis. In another
three cases PMD-TCD proved paradoxical MES
through the anterior communicating artery from the
symptomatic side to the contralateral side with
asymptomatic ICA occlusion.
The stroke risk factors in patients with and without
MES are presented in Table 2. There were no signifi-
cant differences in age, gender, current smoking,
hypertension, hyperlipidemia, grade of symptomatic
side ICA stenosis and type of last ischemic event
before TCD monitoring.
The results suggest an inverse correlation between
the time since the last symptoms and the number of
MES within 30 minute monitoring (Spearman’s rank
correlation coefficient 0.189, p¼ 0.009). Furthermore,
the median (IQR) time since the last ischemic event
symptoms was shorter in the patient group with
MES [þ] than in MES [] (19 (33.5) vs. 38 (55.5)
days; Mann-Whitney U test, p¼ 0.013).
In 7/197 symptomatic vessels (3.6%), MES were eli-
cited by proximal comp-CCA. But in six out of seven
spontaneous MES were recorded within 30 minute
monitoring. No MES appeared on the asymptomatic
side during comp-CCA. Comp-CCA showed poor
intracranial collateral compensation on the symptom-
atic side in another six patients, in whom MCA flow
velocities almost disappeared during ipsilateralTable 2. Incidence of various stroke risk factors in subjects with







Age (m SD)* 70.3 8.0 69.1 8.9 0.3
Gender (male), n (%) 49 (77.8) 112 (83.6) 0.4
Hypertension, n (%) 50 (79.3) 99 (73.9) 0.4
Hyperlipidaemia, n (%) 43 (68.3) 98 (73.1) 0.7
Diabetes, n (%) 13 (20.6) 32 (23.9) 0.3
Angina pectoris, n (%) 13 (20.6) 24 (17.9) 0.7
Myocardial infarct, n (%) 11 (17.4) 23 (17.2) 0.8
Current smokers, n (%) 17 (27.0) 44 (32.8) 0.4
Symptomatic
event-stroke, n (%)
24 (38.1) 53 (39.6) 0.9
Symptomatic event-TIA, n (%) 39 (61.9) 81 (60.4) 0.8
Number of days since last
event (m SD)**
33.1 34.8 49.9 41.2 0.013
Symbols as in Table 1.
* Student’s unpaired two-tailed t test;
** Mann-Whitney U test;
The table presents absolute numbers and percentage in brackets of
cases with and without detected micro-embolic events.comp-CCA. Two of these six patients experienced
mild hypoesthesia in the contralateral hand but it
resolved immediately after stopping the test, and
micro-embolic signals were not detected.
Data of 191 symptomatic ICA stenoses were used
to correlate the occurrence of MES with the intra-
stenotic peak systolic and end diastolic velocities
(Table 3). No significant differences in blood flow ve-
locities between MES [þ] and MES [] ICA stenoses
were found.
The ultrasound plaque characteristics of the symp-
tomatic side were evaluated in all 197 patients. Plaque
types in MES [þ] and MES [] groups are presented
in Table 4. In 11 cases plaques were not classified
and attributed to any particular type in Gray-Weale
Scale. They were defined as ‘unidentified type’ in
the study. The result failed to demonstrate any
predominance in embolic activity comparing different
types of symptomatic side plaques (Fisher’s exact test,
p> 0.05). Additionally, the number of MES detected
within 30 minute monitoring did not differ in sub-
groups with different type of plaque (Kruskal-Wallis,
p> 0.05).
Furthermore, we correlated the occurrence of MES
with plaque types excluding all shadowing and
unclassified plaques (Table 5). The embologenic activ-
ity showed a tendency to be more prevalent in
patients with plaque type 1e2 (predominantly echo-
lucent) rather than 3e4 (predominantly echogenic)
respectively, ( p¼ 0.07).Discussion
CEA significantly reduces the incidence of stroke in
patients with symptomatic extracranial carotid artery
stenosis, but in some cases this evidence may be of
limited help to the clinician who has to make decisions
for the individual patient. In patients with symptom-
atic 70e90% stenosis, the three-year overall risk of
ischemic stroke could be reduced by about 50%. How-
ever, only 20% of these patients will have a majorTable 3. Intrastenotic blood flow velocities within symptomatic
ICA stenosis 70% with presence (MES [D]) or absence of micro-
embolic signals (MES [L])





PSV (m/s) 4.47 1.46 4.45 1.66 0.9
EDV (m/s) 1.78 0.88 1.77 0.93 0.9
PSV e peak systolic velocity;
EDV e end diastolic velocity;
Student’s unpaired two-tailed t test;
Note: 6 cases with string blood flow pattern were excluded.
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Table 4. Atherosclerotic plaque type according to Gray-Weale in
MES [D] and MES [L] patients with symptomatic ICA disease




Type 1, N (%) 6 (9.7) 10 (7.4)
Type 2, N (%) 25 (40.3) 39 (28.9)
Type 3, N (%) 22 (35.5) 63 (46.7)
Type 4, N (%) 0 (0) 2 (1.5)
Type 5, N (%) 7 (11.3) 12 (8.9)
Unidentified type (echolucent-echogenic) 2 (3.2) 9 (6.7)
MES [þ] e patients with detected microemboli;
MES [] e patients without detected microemboli;
Fisher’s exact test 4.9, p¼ 0.42.
538 T. Zuromskis et al.stroke on medical treatment alone. Surgery is therefore
of no value in 80% of patients who, despite having se-
vere symptomatic carotid stenosis, will remain stroke-
free on medical treatment alone.2 The percentage of
unnecessary carotid interventions might even in-
crease, adding statins or other new anti-hypertensive
medications to the standard anti-platelet therapy.25,26
In both carotid endarterectomy trials (ECST and NAS-
CET),3,4,27 the randomization of patients for CEA was
exclusively based on the outcome of carotid angiogra-
phy, disregarding the carotid plaque structure and its
embologenic potential.
The statistically significant difference between the
incidence of MES on the symptomatic and asymp-
tomatic sides respectively suggests possible associa-
tions between the occurrence of ischemic events
and micro-emboli. In almost 70% of high grade ICA
stenosis no MES were present, but this could be
partly related to the brevity of our sampling period.
MES were not associated with concurrent symptoms.
Our findings support other reports, that clinically si-
lent MES can be detected in 21e100% of cases when
monitored with varying recording times from 20 min-
utes to four hours.28,29 The time delay between MES
monitoring and the last ischemic event appears to
be an important issue. Our study supports the find-
ings of Markus HS et al.,30 showing that the earlier
after the last event MES registrations are performed,Table 5. Atherosclerotic plaque subtypes in MES [D] and MES
[L] patients with symptomatic ICA disease





(Type 1þ 2), N /Total (%)
31/80 (39%) 49/80 (61%)
Predominantly echogenic
(Type 3þ 4), N/Total (%)
22/87 (25%) 65/87 (75%)
MES [þ] e patients with detected microemboli;
MES [] e patients without detected microemboli;
c2 3.49, df 1, p¼ 0.07.
Eur J Vasc Endovasc Surg Vol 35, May 2008the higher is the prevalence and frequency of
micro-emboli.
Echolucent plaques have been associated with an
increased risk of stroke, since MES were more fre-
quently observed in an-echogenic/hypo-echogenic
plaque than in iso-echogenic/hyper-echogenic carotid
lesions.9,31,32 However, Droste et al. found that the
echogenicity of the plaque did not affect the number
or the presence of MES.33 Our study showed a ten-
dency towards an association between plaque echolu-
cency and the presence of MES ( p¼ 0.07). This trend
suggests that the sample size for echolucent plaques
and the time period for TCD monitoring could be op-
timized in further studies. Thirty minutes MES moni-
toring might not be long enough to identify all
patients with cerebral micro-emboli. However, there
are no objective criteria available for optimum TCD
recording times or for the number of MES needed
per time unit enabling a prediction of unstable plaque
formations.
High blood flow velocities including turbulence
within the stenosis might mechanically provoke
micro-emboli, but we could not find any correlation
between intra-stenotic blood flow velocities in ICA
and the occurrence of MES. However, our data agrees
with observations by Goertler et al.34 that low post-
stenotic blood flow velocities (<20 cm/s) behind
>90% ICA stenosis reduces the appearance of embolic
signals in recently symptomatic patients.
Cardiac source of cerebral micro-emboli was not
excluded in our patients. However, we performed
bilateral MES monitoring and found only two patients
with MES from the contralateral side. Therefore, it is
unlikely that we were exposed to significant cardiac
micro-embolisation, since only a bilateral MESedetec-
tion could be a sufficient explanation for emboli aris-
ing from the heart or aortic arch.8e35 The fact that MES
were mostly detected unilaterally on the symptomatic
side supports the hypothesis that bilateral TCD
monitoring can facilitate the differentiation between
cardiac and carotid embolic sources. We believe there-
fore, that the occurrence of MES is an indicator of
plaque instability in symptomatic high-grade ICA ste-
nosis, which must be rapidly treated by CEA accord-
ing to the meta-analysis of ECSTand NASCET4,11,36e38
and the ‘‘Report of the Therapeutics and Technology
Assessment Subcommittee of the American Academy
of Neurology’’.39
Comp CCA helps to identify the intracranial ves-
sels and to assess the collateral capacity within the cir-
cle of Willis.25 Its complication rate is very low when
performed as proximally as possible25 and as long as
common carotid artery stenosis and carotid artery dis-
section is excluded by CDI. During the last decade, we
539Prevalence of Micro-Emboli in Symptomatic High Grade Carotid Artery Diseasehave routinely performed approximately 4,000 TCD
investigations with comp-CCAwithout any complica-
tions. In this study, 6/197 patients had short-lasting
symptoms of numbness in the contralateral hand dur-
ing comp-CCA. These symptoms resolved completely
immediately after stopping the test and are explained
by insufficient collateral compensations during comp
CCA. As a result, the surgeons were prepared for in-
tra-operative shunting which was performed in four
of these patients because of low carotid stump pres-
sures. MES were provoked by comp-CCA in seven
cases, six of these also displayed MES spontaneously
during TCD monitoring.
Collateral embolisation through the anterior com-
municating artery from one side to another has been
described in the literature.40 One of the sources for
those MES could be fragmentations of the soft distal
thrombus tail within an occluded ICA. However,
this was not the case in our study, since PMD-TCD
proved in all three cases a paradox MES movement
through the anterior communicating artery.Conclusion
Cerebral micro-embolisation occurs predominantly in
the ipsilateral hemisphere of symptomatic carotid
artery disease. Our study showed that time since the
last ischemic event is essential in MES detection. We
did not found any correlation between incidents of
MES, intra-stenotic blood flow disturbances and
stroke risk factors. Plaque echogenicity as described
by modified Gray-Weale scaling showed only a
tendency to correlation with MES occurrence and is
therefore of limited value in clinical decision making.
Future studies are therefore needed to design plaque
morphology algorithms that identify vulnerable
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